Spero Therapeutics Inc (SPRO) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 100.00%- | 0.26 | 41.30 | 5.44 | 14.19 |
27.32%9.93 | 7.80 | 9.89 | 13.36 | 16.63 | |
| Research and Development | 18.05%3.43 | 2.91 | 5.59 | 8.60 | 10.67 |
| Operating Income/Loss | 31.68%-9.93 | -7.54 | 31.41 | -7.92 | -2.44 |
| Nonoperating Income/Loss | 11.64%0.37 | 0.34 | 0.38 | 0.53 | 0.74 |
32.61%-9.55 | -7.20 | 31.52 | -7.38 | -1.70 | |
| Attributable To Parent | 32.61%-9.55 | -7.20 | 31.52 | -7.38 | -1.70 |
| Basic Average Shares | 1.20%57.97 | 57.28 | - | 56.28 | 56.03 |
| Diluted Average Shares | 1.20%57.97 | 57.28 | - | 56.28 | 56.03 |
| Basic Earnings Per Share | 23.08%-0.16 | -0.13 | - | -0.13 | -0.03 |
| Diluted Earnings Per Share | 23.08%-0.16 | -0.13 | - | -0.13 | -0.03 |